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Summary.-The growth of carcinoma of the human large bowel was studied in the
first 2 passages in immune deprived mice. The tumours were obtained from large
bowel resections on 3 people. There was a strong histological similarity between
the patient's tumour and the tumour that grew subcutaneously in the mice 2-8
months after implantation. One dissimilarity observed was a higher mitotic index
in some of the tumours growing in the immune deprived animals. In the second
passage of the bowel tumours, cells were implanted into groups of 8-10 animals in
the following sites: subcutaneous, intramuscular, intravenous, intrahepatic, intra-
peritoneal and intrathoracic. Growth of tumour was observed from all 3 tumours
when they were implanted subcutaneously, intramuscularly, intraperitoneally and
intrathoracically. Infiltration of muscle by tumour was a frequent finding. Lung
metastases developed after intravenous injection of cells in 1 of the 3 tumours. In
none of the 3 tumours did growth follow injection of cells directly into the substance
of the liver. On no occasions were spontaneous metastases observed.
CARCINOMA arising in the large bowel
in man can be transplanted successfully
subcutaneously in immune deprived
animals (Povlsen and Rygaard, 1971;
Castro, 1972; Cobb, 1972). If we wish to
use this xenograft model to learn more
about a tumour in man, we need to under-
stand to what extent transplantation to a
xenogeneic host alters the tumour cell
population. The work described in this
article was designed to study the changes
likely to occur when carcinoma of the
large bowel is transplanted into immune
deprived mice and, in addition, when this
first passage tumour population is trans-
planted into a further group of immune
deprived mice. The study of the second
passage was instituted because occasions
could be foreseen when insufficient of the
primary tumour would be available to
carry out all studies on the first passage.
In the present study passage 1 of the
tumour was only carried subcutaneously,
using a small amount ofprimary (patient's)
tumour. When the tumour material had
grown to a sufficient volume it was pre-
pared for a second passage; on this occa-
sion the tumour was implanted subcu-
taneously, intramuscularly, intravenously,
intrahepatically and by injection into the
pleural and peritoneal cavities. The
results, in terms of tumour growth and
invasiveness, are recorded below and the
subsequent discussion is concerned with
the problems ofinterpreting the behaviour
ofthe tumour in mice in terms ofits likely
behaviour had those cells been allowed to
remain in the human host.
MATERIALS AND METHODS
Experimental animals-.Male and female
CBA/lac mice were used. The breeding
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stock was obtained from the Laboratory
Animals Centre, Carshalton, Surrey, England.
The mice were given sterile food and sterile
water ad libitum. The sex of the animals
was chosen to match the sex of the patient.
Technique of immune deprivation. The
technique used was based on that developed
by Miller in this Institute and published in
1963, although in the present work younger
animals and a higher dose of irradiation were
used. The mice were thymectomized at 4
weeks of age and 4 weeks later they were
given 900 rad whole body irradiation.
Irradiation was given at 60 rad/min using a
220 kV x-ray machine, h.v.l. 04 mm3, focal
distance 100 cm. Without a bone marrow
graft this dose ofirradiation w%vould have been
lethal. Within 6 hours of irradiation each
mouse received 5 x 106 syngeneic femoral
bone marrow cells intravenously. The ani-
mals received the tumour graft between 2
and 4 -weeks after irradiation.
Source of tumours
Patient W.H. (Tumour numberP76).-The
patient was a 66-year old married. w%voman
wrho had complained of tiredness and weak-
ness for 8 months, and diarrhoea for 1 month.
On admission to hospital she had a large
pelvic mass and was very anaemic. At
laparotomy a partial colectomy was per-
formed for carcinoma of the colon. Because
of involvement of other organs it was neces-
sary to carry out partial ileectomy and partial
cystectomy. The patient died 2 months
later from bronchopneumonia and recurrent
carcinoma ofthe colon. Thetumourremoved
at operation was a poorly differentiated
adenocarcinoma. There was infiltration of
the wall of the large and small intestine and
ofthebladder. Therewasinvasion bytumour
oflymphatic vessels and veins. The regional
lymph nodes were also involved with tumour.
Patient R.G. (Tumour number P116).-
The patient was a 65-year old male who had
complained of pain and swelling of the
abdomen for 2 months. Diarrhoea had been
intermittent but without blood. A left
hemicolectomy was performed for adeno-
carcinoma of the colon. The tumour was a
well differentiated, mucus producing, adeno-
carcinoma and had metastasized to the
regional lymph node. Two years later
(June, 1973) the patient is alive and well.
Patient I.S. (Tumour number P184).-
The patient was a 72-year old spinster who
had had intermittent diarrhoea for 6 months.
Rectal bleeding had been observed for this
period. Hartman's operation for resection
of the rectum was performed for carcinoma
of the rectum. The tumour -was a poorly
differentiated adenocareinoma and had spread
directly to involve the uterus. The patient
recovered well from the operation but was lost
to followN up.
First (subcutaneous) tumourpassage in animals
Two of the 3 tumours (P76 and P184)
were obtained from the operating theatre and
implanted in the animals within 3 hours of
resection. The third tumour (P116) was
held at -190°C in 1000 dimethyl sulphoxide
and9000 Fischer's medium for3 months before
implantation. Slices oftumour each approx-
imately 3 x 3 x 1 mm were selected from
different regions of each tumour and one
slice of tumour implanted subcutaneously
into the right flank ofeach of5-8 mice (Table
I). Adjacent pieces of tumour were fixed
in Bouin's solution and prepared for histo-
logical examination.
In the first passage in all tumour bearing
mice, when the tumour had reached approxi-
mately 10 cm3 950% of the tumour mass was
removed together with an area of overlying
skin. A sample of tumour, including skin,
was taken for histological study. All animals
were allowsNed to survive until the local
recurrence of tumour necessitated their
destruction. At necropsy the tumour and
adjacent skin and muscle were retained for
histological examination together with the
axillary lymph nodes, lungs (inflated with
fixative), heart, thyroid, liver, suparenals,
kidneys, testes or ovaries, pancreas, small
and large intestine. The tissues wNere fixed
in Bouin's fluid.
Preparation of tumour cell suspension for
injection.-Enzymes were used to separate
passage 1 tumour cells for injection into a
second group of mice to give passage 2.
Finely chopped tumour was incubated for 2
hours in a solution ofTC199 containing 0.25%
ovine hyaluronidase (Seravac Laboratories,
Maidenhead, Berkshire, England), and 0 25%
collagenase (Sigma Chemical Company, St
Louis, U.S.A.). After 2 hours incubation the
tissue preparation was passed through a
gauze filter to remove the larger pieces of
stroma and tumour and the resulting suspen-
sion of cells was washed 3 times in phosphate
buffered saline before injection into mice.
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TABLE I.-Growth of Carcinoma of Colon and Rectum Implanted Subcutaneously
into Immune Deprived Mice
Histology
Poorly differentiated
adenocarcinoma of colon
Well differentiated
adenocarcinoma of colon
Moderately well
differentiated
adenocarcinoma of rectum
Mitotic indext
Time (months) from , A
9 mm3 to 10 cm3 Patient Passage 1 Passage 2
" Takes "* -passage It tumour (S/C)§ (S/C)
2/8 3-8 0 5 3-2 3
3/5
3/8
5-8
6-7
0.1 0-4 04
0 4 0-3 0 4
* A "take " was recorded if the tumour grew to 10 cm3.
t Passage 1 was the growth of tumour implanted from the patient.
t The mitotic indices were of the first tumour to grow to 10 cm3 in passages 1 and 2. 1 x 104 cells
were counted to estimate a mitotic index.
§ S/C subcutaneous tumour.
TABLE II. Number of " Takes " in Passage 2 ofP76, P116 and P184for 6 Sites
of Implantation
Site and nature
of implant
Subcutaneous
(3 x 3 x 1 mm)
Intramuscular
(3 x 1 x 1 mm)
Intraperitoneal
(1 x 106 viable cells)
Intrapleural
(1 x 106 viak," -.clls)
Intrahepatic
(2 x 105 viable cells)
Intravenous
(2 x 105 viable cells)
Takes* (passage 2)
P76 P116 P184
8/10 10/10 6/10
10/10 10/10 10/10
8/10 10/10 9/9
8/8 9/9 6/9
0/10
0/10
0/10
4/10
0/10
0/10
* A " take " was recorded when the extent of tumour growth necessitated the destruction of the animal,
except in the case ofintravenous injection of cells when " takes " were recorded when there was macroscopic
and/or microscopic evidence of one or more lung metastases at the termination ofthe experiment.
The viability of cells was assessed micro-
scopically by their ability to resist staining
with nigrosin (Kaltenbach, Kaltenbach and
Lyons, 1958).
Second tumour passage in animals
The first mouse to bear a tumour of10 cm3
in passage 1 of each of the 3 implanted
tumours (P76, P116, P184) supplied all the
tumour tissue for the study of the second
passage of tumour (passage 2). Either
pieces of tumour, or a cell suspension of
tumour, from these 3 mice were implanted
into groups of 8, 9, or 10 immune deprived
mice by one of the following routes: subcu-
taneous, intramuscular, intrahepatic, intra-
venous, intraperitoneal or intrapleural (intra-
thoracic) (Table II). No animal was im-
planted with tumour in more than one site.
For the subcutaneous implantation slices of
tumour, 3 x 3 x 1 mm, were implanted into
the right flank. Pieces oftumour, 3 x 1 x 1
mm, were implanted intramuscularly in the
quadriceps group of the right hind leg of
other groups of mice. Cell suspensions
containing single cells and clumps of up to 10
cells were inoculated intraperitoneally
(1 x 106 viable cells), intrapleurally (1 x 106
viable cells), intravenously (2 x 105 viable
cells) and directly into the substance of the
liver during laparotomy (2 X 105 viable
cells). Post mortem examinations were car-
ried out on all animals, when they became
moribund, or 9 months after implantation
when all the remaining animals were killed
at the termination of the experiment. All
organs were examined for macroscopic patho-
logy and the following organs taken for
Tumour
No.
P76
P116
P184
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microscopic examination: lung, heart, thy-
roid, ovary or testis, suprarenal, kidney, liver,
pancreas, small and large intestine. The
tissues were fixed in Bouin's fluid. Sections
were cut, and stained with haematoxylin
and eosin and/or periodic acid-Schiff. The
numbers of animals inoculated and the
numbers of animals subsequently bearing
tumours are given in Table 11.
Chroinosome analysis-.A mouse bearing
subcutaneously the tumour P76 in passage 2
was injected subcutaneously with 01 mg of
Colcemid (Ciba Pharmaceutical Products,
Basle, Switzerland). Two hours later the
tumours was dissected from the animal and a
tumour cell separate made by mechanically
forcing the tumour through a fine metal
sieve. A preparation of these tumour cells
was made for chromosome analysis in order
to confirm that the tumour was of human
origin.
Bacteriological study.-Tissue adjacent to
those areas of tumour selected for transplan-
tation in all experiments were smeared onto
blood agar plates and incubated aerobically
for 72 hours.
RESULTS
Behavioar of P76 in immune deprived
mice
The tumour grew progressively in 2
of the 8 immune deprived mice into which
pieces of the primary tumour were
implanted (Table I). After 3 months
the most rapidly growing tumour had
reached an estimated volume of 10 cm3
and this tumour material was used for
the passage 2 studies. The tumour in the
second mouse did not reach 10 cm3
until 8 months after implantation. The
histological appearance oftumourremoved
from the 2 mice closely resembled that of
the patient's tumour. Many areas of the
tumour in the mice were indistinguishable
histologically from the primary tumour in
the patient. The mitotic index of the
tumour material from the mouse was
noticeably higher than the mitotic index
in the patient's tumour (Table I). The
tumour growing subcutaneously in the
mice had infiltrated and destroyed areas
of the subcutaneous muscle and in one
animal this led to ulceration of the skin
(Fig. 1). There was no evidence of
infiltration of lymphatic vessels or blood
vessels by the tumour in the mouse,
although this had been the case in the
primary tumour when growing in the
patient.
In the second generation of subcu-
taneous passage in mice (passage 2) 8 of
the 10 implanted mice grew tumours
(Table II). The first tumour to grow to
10 cm3 did so 2 months after the implan-
tation of a 9 mm3 piece of tumour. The
histological appearance was similar to the
tumour of passage 1 with a similar
mitotic index (Table I). There was
infiltration by the tumour of the underly-
ing abdominal muscle (Fig. 2). In none
of the subcutaneously implanted mice
from passages 1 and 2 were regional lymph
nodes involved with tumour cells.
The attempts to establish growth of
the tumour P76 in mice by intravenous
injection of cells, or injection of cells
directly into the liver, were without
success. Following injection of tumour
cells directly into the pleural cavity, the
tumour grew extensively on the parietal
pleura and only occasionally on the vis-
ceral pleura. The histological appearance
of the tumour was essentially that of the
patient's tumour, although the stromal
response appeared to be less than that of
the patient's tumour. There appeared
to be some selection of cells capable of
forming isolated hollow spheres of tumour
cells, having only a small area of attach-
ment to the pleura. Following intra-
peritoneal injection of the cell suspension,
the tumour became established mostly
on the greater and lesser omenta and the
peritoneal surface of the diaphragm.
Occasionally other areas of the parietal
and visceral peritoneum provided sites
for attachment of tumour. As with the
growth in the thorax, the tumour was
supported by a minimum of stroma.
There was no histological evidence of
infiltration of the abdominal organs but
the track of the injecting needle through
the abdominal wall was frequently identi-
fied by infiltration of abdominal muscle
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FIG. 1. The infiltration of subcutaneous muscle and extension of tumour (P76) into the dermis at
the periphery of an area of ulceration of the skin in the mouse. Polymorph infiltration at the site
of ulceration indicates tissue necrosis and perhaps infection. The dermis encapsulating the
tumour is infiltrated with mononuclear cells and a small number of polymorphs. H. & E. x 196.
by tumour. The tumour implanted into
the muscle of the hind limb grew in all
animals, illustrating clearly the ability
of the tumour to grow and to infiltrate
striated muscle in the mouse. Tumour
was not observed in the regional lymph
nodes of the hind limbs.
Behaviour ofP116 in immnune deprived
mice
The tumour implanted into 5 immune
deprived mice grew progressively in 3 of
the animals and grew for only a short
period, before regressing, in the other 2
animals (Table I). The growth oftumour
and subsequent regression in these 2
animals was assessed only by palpation; a
biopsy was not taken to confirm the
presence of tumour. In the 3 mice in
which the tumour grew progressively the
histology was that of a well differentiated,
mucus secreting adenocarcinoma of the
colon. Its appearance was very similar
to the primary tumour in the patient
(Fig. 3 and 4). The tumour growing in
the mice appeared to have greater lympho-
cyte infiltration than did the patient's
tumour although the difference was mar-
ginal. As with P76, the mitotic index of
passage 1 of P116 in the mice was signifi-
cantly higher than in the patient (Table
I). Passage 2 ofP116 in the mice grew in
10 out of 10 subcutaneously implanted
animals (Table II). The tumour reached
a volume of 10 cm3 in some ofthe 10 mice
more quickly in passage 2 than in passage
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FIG. 2. Infiltration of the muscle of the abdominal wall of the mouse by carcinoma of the colon (P76). The tumour has infiltrated between individual muscle fibres of the abdominal wall. H. & E. x 235.
1. However, the extensive formation of
mucin and the resultant uncertainty of
the exact cellular content ofthe implanted
tumour pieces made measurement of
tumour volume and estimation of tumour
volume doubling time oflittle value. The
subcutaneous and intramuscular growth of
passage 2 showed the ability of this
tumour to infiltrate adjacent muscle.
The tumour grew well when injected
as a cell suspension intrapleurally and
intraperitoneally. Attachment was pre-
dominantly to the parietal pleura and
diaphragm in the thorax and to the vis-
ceral peritoneum, particularly the omen-
tum in the abdomen. It was not possible
to obtain growth of the tumour by injec-
tion of 2 x 105 live cells into the sub-
stance of the liver. In 4 of the 10 mice
receiving 2 x 105 cells intravenously, scat-
tered lung metastases were observed
macroscopically when the 10 mice were
killed 9 months after the intravenous
injection of the cells. The metastases
appeared microscopically as small groups
ofwell differentiated adenocarcinoma cells
suspended in mucin (Fig. 5).
Behaviour ofP184 in immune deprived
mice
The rectal tumour P184 grew progres-
sively in 3 of 8 immune deprived mice
(Table I). The first tumour reached
10 cm3 6 months after implantation.
This tumour material was used for passage
2. The passage 1 tumour in all 3 mice
grew as a moderately well differentiated
rectal carcinoma. In parts ofthe passage
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FIG. 3. P1 16. An area of well differentiated, mucin producing,
in the patient R.G. H. & E. x 160.
1 tumour, groups of signet ring cells were
observed floating in pools of mucin. The
pools of mucin were separated by thin
connective tissue septa. In other areas
the mucin secretion was negligible. This
histological appearance was also present
in sections from the primary tumour in the
patient. In addition, thepatient'stumour
contained areas of well differentiated
rectal carcinoma showing very little loss
of nuclear polarity and extensive stromal
support. Such areas were not represented
in the tumour growing in the immune
deprived mice. The mitotic index of the
subcutaneous passages 1 and 2 of P184
in mice was not significantly different
from that of the primary tumour. There
was infiltration of subcutaneous and
adenocarcinoma
abdominal musculature by the tumour on
passage 1 (Fig. 6) and passage 2 but no
evidence of infiltration of lymphatic
vessels or veins and no metastatic spread
to regional lymph nodes.
Efforts to establish growth of P184
in immune deprived mice by intrahepatic
and intravenous injection of cells failed
(Table II). As with P76 and P116, the
tumour grew successfully following intra-
pleural and intraperitoneal inoculation.
Intrapleurally, the tumour grew on the
parietal pleura which provided stromal
support for growing clumps of moderately
well differentiated rectal carcinoma cells.
In the mice killed because of extensive
intraperitoneal growth the visceral peri-
toneum and diaphragm provided major
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FIG. 4. P116. Well differentiated, mucin producing, adenocarcinoma of the colon in passage 1
in an immune deprivecl mouse. H. & E. x 160.
sites for the implantation of tumour. On
occasions abdominal organs had attached
tumour masses but these organs were
never observed to be infiltrated by the
tumour.
ChroMosome analysis
The chromosome analysis of tumour
from passage 2 of P76 showed the tumour
cells to be unequivocally of human origin.
DISCUSSION
There can be little doubt that carci-
noma of the large bowel, when trans-
planted into immune deprived animals,
will provide a useful method for the study
of this tumour. The clinical value will be
related to the similarity of the tumour
in the animals tothe tumour in the patient.
Carcinoma of the large bowel responds
poorly and erratically to chemotherapy
and there is a need for a reliable method of
assessing the likely sensitivity of a
patient's tumour to cytotoxic agents.
Cytotoxic agents are given, either " pro-
phylactically " after bowel resection or
when the tumour recurs. In either case
the cell population ofthe resected primary
tumour may differ in composition and
drug sensitivity from the population
remaining in the patient. This could
make the growth of the primary tumour
in immune deprived animals of only
limited value for assessing the chemo-
sensitivity of the residual tumour. Simi-
larly, the population of cells that eventu-
allysucceedsingrowingin immunedeprived
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Fie. 5. Adenocarcinoma of coloni in peripheral lung field. Cells from passage 1 of the colonic
carcinoma P116 owere injecte(1 intravenously 9 months previously. The tuimouir metastasis is of
moderately well clifferenitiate(i type pro(lucing mucin. The metastasis has hel(d the attention of
large intumbers of monontuclear cells, few of which are einterinig the mucin. H. & E. x 160.
animals may have a different drug sensi-
tivity from both the primary and the
recurrent tumour in the patient. These
differences in sensitivity, if they occur,
might be due to biochemical differences
in the cells themselves, differences in
blood supply or differences in tumour cell
kinetics. It was observed in P116 and
P76 that the mitotic index of the primary
patient tumour was less than that of the
first generation growing in the mouse.
The lower mitotic index in the patient
material may, tosome extent, be accounted
for by a delay in fixation of the specimen,
which can lead to cells completing mitosis.
On the other hand, a relatively large
primary tumour in man could be expected
to have a poorer blood supply than the
tumour growing subcutaneously in the
mouse and this might account for the
differences in mitotic index in some cases.
The increased percentage of proliferating
cells in the xenografted tumour could
cause this tumour to respond more
favourably than the primary tumour to
antimitotic agents. If attempts are to be
made to use the xenografted tumour for
assessing sensitivity to cytotoxic drugs or
irradiation, it will be necessary to gain
further information about the cell kinetic
and metabolic changes that take place in a
human primary tumour when it is trans-
planted into animals.
When the rectal carcinoma P184 was
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FiG. 6. Adenocarcinoma of the rectum infiltrating muscle. The moderately well differentiated
rectal carcinoma P184 is seein to be infiltrating the abdominal wall in an immune deprived mouse.
There is some mucin pro(luction. H. & E. x 90.
transplanted into immune deprived mice
it failed to develop the complete spectrum
of histological features of the primary
tumour. It is possible that the pieces of
tissue implanted into the mice did not
contain tumour tissue representing all the
histological featuresoftheprimarytumour.
On the other hand, it is possible that the
mouse cannot develop the stromal res-
ponse necessary to support some human
tumour tissue patterns. The chemo-
therapist and radiotherapist may not need
to be unduly concerned by the failure of
the tumour in the mouse to retain exactly
the histological features of the primary
tumour for we have no proofthat a change
in histological pattern of a tumour on
transplantation invariably indicates a
change in chemosensitivity or radiosen-
sitivity. Nevertheless, the chemothera-
pist or radiotherapist seeking to assess the
likely sensitivity of a patient's tumour by
transplanting biopsied material into
immune deprived animals would be wise,
whenever possible, to transplant several
pieces of tumour from different areas of
the primary tumour in order to get an
overall view of the tumour.
It was not possible to obtain growth of
the colonic and rectal carcinomata by the
implantation of cells directly into the
substance of the liver. This is perhaps
surprising in view of the high frequency
of metastatic spread of these tumours to
the liver in man. On the other hand, we
should not assume that those tissues that
will support metastatic growth of a
tumour in man will also support growth of
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the human tumour when it is implanted
into the mouse.
There was little difficulty in establish-
ing growth ofpassage 2 ofthe 3 tumours in
the subcutaneous, intramuscular, intra-
peritoneal and intrapleural sites. It is
not possible from the results to suggest
which of these 4 sites is likely to be the
most efficient in the support of implanted
large bowel tumour from patients.
The criterion for tumour " take " in
the present experiments was the develop-
ment of a relatively large tumour mass,
approximately one quarter of the total
body weight. On occasions, masses were
observed at the site of implantation which
regressed before reaching the size required
to register a " take ". The size of 10 cm3
was chosen to be the minimum necessary
to register a " take" because it was
known that once a tumour had reached
these dimensions it would not regress
spontaneously.
Carcinoma ofthe largebowel inman has
usually infiltrated the muscularis mucosae
and the muscle of the bowel wall by the
time it is observed clinically. It was
interesting to note that infiltration of the
subcutaneous muscle and the muscle of
the abdominal wall was observed in the
first and second passages ofthe 3 tumours.
The least differentiated tumour (P76)
also infiltrated the dermis and produced
skin ulceration.
The fraction of tumour " takes " in
passage 2 was greater than in passage 1 for
all 3 tumours. This increase may have
been due to a higher percentage of cells
with clonogenic capacity being present
in the tumours implanted on the second
passage. This increased percentage of
cells with clonogenic capacity would be
above the threshold of cell number neces-
sary to establish the graft. Alternatively,
the presence of human stroma in the
initial implant from the patient could
have increased the likelihood of graft
rejection. It is also possible that the
implanted tumour material from the
patient carried infection not registered on
blood agar uinder aerobic conditions. If
transplantation oftumour from the patient
into the mouse were to lead to selection
of those cells that will grow most easily
and proliferate most rapidly in the mouse,
then it might be expected that implan-
tation of such tissue would be more
successful in the second passage where
they will form a higher percentage of the
inmplanted cells.
Volume doubling time was estimated
at the commencement of these experi-
ments but after the initial histology re-
vealed that P116 was approximately
95%0 mucin and 5% tumour tissue, it
was realizedthat simplymeasuringexternal
diameter of the tumour mass would not
only represent changes in tumour popula-
tion but also changes in the balance of
mucin production and absorption, and so
estimations of tumour volume doubling
time were abandoned.
In conclusion, it is apparently possible
to obtain progressive expansion of a
tumour cell population of carcinoma of
the human large bowel in immune deprived
mice. Areas of the tumour in the mice
have a close histological resemblance to
the primary tumour in the patient. How-
ever, there are also apparent differences
in tumour structure, invasiveness and
mitotic indices and caution should
be exercised before using the tumour
growing in immune deprived mice as a
replica of the tumour remaining in the
patient.
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